Abstract Background Oral methotrexate (MTX) is the first-line therapy for patients with rheumatoid arthritis (RA). However. approximately one quarter of patients discontinue MTX within 12 months. MTX failure. https://enchantasyers.shop/product-category/body/
Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study
Internet 15 hours ago xahgcycx0hjf7u
Web Directory Categories
Web Directory Search
New Site Listings